TrialBone marrow transplantation2016
A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.
J Shang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it